mazdaki

CERUS Will Break out of the wedge

做多
NASDAQ:CERS   Cerus Corporation
0
FDA approval.
Start of US customer base
Double bottom on a daily base.
Cup and Handle formation.
Wedge formation but not pierced yet.
First Target raised to $8 ish
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。